CAPRICOR THERAPEUTICS, INC.: MONTANOVA CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Montanova Capital, LLC amended its Schedule 13G stake filing for Capricor Therapeutics, Inc., per SEC accession 0000919574-26-007761. The filing updates the investment firm's reported ownership position in the biopharmaceutical company. Schedule 13G amendments are typically filed by passive investors to reflect changes in beneficial ownership. The exact revised share count and percentage were not disclosed in the headline. Investors will watch for further 13G or 13D filings to gauge institutional interest in Capricor.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Capricor Therapeutics, Inc., Montanova Capital, LLC